FDA Releases Risk Summaries For Newer Drugs

WASHINGTON, June 15 (Reuters) - U.S. health officials have started releasing summaries of safety reviews for recently approved medicines as part of their efforts to inform doctors and consumers about potential side effects.

MORE ON THIS TOPIC